ArticleInvestigational new drugs2019

Durable response to the ALK inhibitor alectinib in inflammatory myofibroblastic tumor of the head and neck with a novel SQSTM1-ALK fusion: a case report.

Kazunori Honda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.